Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 44 of 100
FDA Recalls Children’s Cough Syrup Sold At Dollar General Stores
By
Brittany Shoot
March 21, 2019
Leadership
Novartis CEO: It’s Time to “Pivot Towards Transformational Innovation”
By
Susie Gharib
March 20, 2019
National Portrait Gallery Won’t Proceed With Donation From Purdue Pharma’s Sackler Family
By
Don Reisinger
March 20, 2019
Fewer People Are Strategizing With Prescription Drug Choices to Control Their Health Care Costs
By
Erik Sherman
March 19, 2019
Opioid Prescriptions Are Down—But Patients Are Using Them Longer
By
Don Reisinger
March 18, 2019
UnitedHealth Expands Drug Rebate Program to Consumers
By
Erik Sherman
March 12, 2019
U.S. Drug Prices, But Not Out-of-Pocket Costs, Are the World’s Highest
By
Erik Sherman
March 8, 2019
Trump Administration Hands Out Record Number of Orphan Drug Approvals
By
Erik Sherman
March 4, 2019
Drugmaker Lilly to Launch a Half-Price, Generic Version of Its Top-Selling Insulin
By
Bloomberg
and
Thomas Mulier
March 4, 2019
Drug Companies Have Big R&D Expenses and Still Make Large Profits
By
Erik Sherman
March 1, 2019
FDA Recalls More Blood Pressure Medication
By
Brittany Shoot
February 27, 2019
Senator Calls Tying Drugmaker CEO Pay to High Drug Price ‘Problematic’
By
Erik Sherman
February 27, 2019
GE’s Turnaround Plan Gets a Boost With $21.4 Billion Sale of Biopharma Unit to Danaher
By
Bloomberg
,
Yueqi Yang
and
Richard Clough
February 25, 2019
CVS Stock Plummets as 2019 Looks Like It Will Be a ‘Major Disappointment’ for Investors
By
Bloomberg
and
Robert Langreth
February 20, 2019
Big Pharma Companies Use Loophole on Old Drugs for New Profits
By
Erik Sherman
February 19, 2019
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’
By
Emma Burleigh
Politics
Meet the Palm Beach billionaire who paid $2 million for a private White House visit with Trump
By
Tristan Bove
Cybersecurity
Top AI leaders are begging people not to use Moltbook, a social media platform for AI agents: It’s a ‘disaster waiting...
By
Eva Roytburg